"Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment. (1st August 2015)

• Record Type: Journal Article
• Authors: Batchelder, A.W.; Peyser, D.; Nahvi, S.; Arnsten, J.H.; Litwin, A.H.
• Is Part Of: Drug and alcohol dependence. Volume 153(2015)
• Page Start: 66
• Page End: 71
• Publication Date: 2015-08-01
• Subjects: Hepatitis C -- Injection drug use -- Methadone maintenance -- Shame -- Internalized stigma; Drug abuse -- Periodicals; Alcoholism -- Periodicals; 616.86
• DOI: 10.1016/j.drugalcdep.2015.06.007
• Languages: English
• ISSNs: 0376-8716

Abstract

Highlights: We interviewed 31 methadone-maintained adults enrolled in integrated hepatitis C (HCV) treatment. Participants described psychological and behavioral transformations from treatment. Integrated HCV treatment may be able to reduce shame and improve overall self-care. Abstract: Background: Hepatitis C (HCV) is a significant public health problem that primarily affects current and former substance users. However, individuals with a history of substance use are less likely to have access to or engage in HCV care. Psychological and behavioral barriers prevent many HCV-infected individuals from initiating or engaging in HCV treatment. This study aimed to investigate the psychological and behavioral experiences of current and former substance users receiving HCV treatment within a combined methadone and primary care clinic in the United States. Methods: We conducted 31 semi-structured qualitative interviews with opioid-dependent adults enrolled in an integrated HCV treatment program within a methadone maintenance clinic in the Bronx, NY. We used thematic analysis, informed by grounded theory, and inquired about perceptions of HCV before and after initiating HCV treatment, reasons for initiating HCV treatment, and the decision to participate in individual versus group HCV treatment. Results: Participants described psychological and behavioral transformation over the course of HCV treatment. These included reductions in internalized stigma and shame related to HCV and addiction, increases in HCV disclosure and self-care, reductions in substance use, and new desire to help others who are living with HCV. Conclusions: Integrating HCV treatment with methadone maintenance has the potential to create psychological and behavioral transformations among substance using adults, including reductions in HCV- and addiction-related shame and improvements in overall self-care.